As of January 31st, 2025, Icade capital stood at €116,203,258.54 divided in 76,234,545 shares.
Subject to approval at the 2025 General Shareholders’ Meeting. The 2024 dividend includes €2.54 per share corresponding to the dividends still due in respect of the capital gain on Stage 1 of the sale of the Healthcare business in 2023.
Subject to approval at the General Shareholders’ Meeting
An interim dividend of €2.16 per share will be paid in cash on March 6, 2025 with the shares going ex-dividend on March 4, 2025
a final dividend of €2.15 per share will be paid in cash on July 3, 2025 with the shares going ex-dividend on July 1, 2025